• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二级护理医院患者丙型肝炎感染的危险因素及结局:一项5年回顾性研究。

Risk factors and outcome of hepatitis C infection among patients in a secondary care hospital: A 5-year retrospective study.

作者信息

Sannathimmappa Mohan B, Zehri Latifa, Al Zadjali Ayat A M, Albalushi Halima M A, Al Saadi Buthaina A A H, Aravindakshan Rajeev, Al-Risi Elham S, Al-Maqbali Saleema, Nambiar Vinod

机构信息

Department of Microbiology and Immunology, College of Medicine and Health Sciences, National University of Science and Technology, Sohar Campus, Sultanate of Oman.

Department of Community Medicine, All India Institute of Medical Sciences, Mangalagiri, Andhra Pradesh, India.

出版信息

J Educ Health Promot. 2024 Jul 11;13:208. doi: 10.4103/jehp.jehp_1326_23. eCollection 2024.

DOI:10.4103/jehp.jehp_1326_23
PMID:39297119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11410161/
Abstract

BACKGROUND

Hepatitis C virus (HCV) infection, predominantly transmitted by exposure to infected blood, remains one of the major public health problems worldwide. This study aims to identify the risk factors of HCV transmission and its chronic complications among the study group.

MATERIALS AND METHODS

This retrospective study was approved by the Research and Ethical Review and Approve Committee (RERAC) of Oman and conducted at a secondary-care hospital situated in the North Batinah region of Oman. The study population included all HCV cases confirmed by positive serology and reverse-transcription polymerase chain reaction tests during their presence at the hospital between January 2017 and December 2022. The relevant data of the study population were retrieved from the hospital electronic health record system. The data were analyzed using the Statistical Package for the Social Sciences (SPSS), Version 26.0.

RESULTS

A total of 177 HCV confirmed cases were included in the study. HCV infection was predominant among males (74%) and individuals of the age group of 21-60 years (74.6%). Genotyping was possible only in 107 cases. Among HCV genotypes, genotype 3 (58.9%) was the most frequently identified, followed by genotype 1 (34.6%). Hemodialysis (21.5%), history of blood transfusion (16.4%), and injection drug use (11.9%) were the major risk factors for HCV infection, while cirrhosis (7.3%) and fatty liver disease (4%) were the most frequently observed chronic HCV complications. HCV infection in the spouse/partner (21.5%), alcohol use (7.3%), and co-infection with hepatitis B virus (2.3%) and human immunodeficiency virus (1.7%) were the other significant factors detected in our study population.

CONCLUSIONS

HCV is a multi-factorial disease leading to severe chronic complications, thus representing a public health threat. This clearly emphasizes the cruciality of HCV community awareness campaigns and enhancement of Omani national guidelines for early screening of high-risk groups as well as effective management of HCV-infected cases to reduce the substantial burden of the disease on patients as well as the healthcare system.

摘要

背景

丙型肝炎病毒(HCV)感染主要通过接触受感染血液传播,仍是全球主要的公共卫生问题之一。本研究旨在确定研究组中HCV传播的危险因素及其慢性并发症。

材料与方法

本回顾性研究经阿曼研究与伦理审查及批准委员会(RERAC)批准,在阿曼北巴提奈地区的一家二级护理医院进行。研究人群包括2017年1月至2022年12月期间在该医院就诊时血清学和逆转录聚合酶链反应检测呈阳性确诊的所有HCV病例。研究人群的相关数据从医院电子健康记录系统中检索。使用社会科学统计软件包(SPSS)26.0版对数据进行分析。

结果

本研究共纳入177例HCV确诊病例。HCV感染在男性(74%)和21 - 60岁年龄组个体(74.6%)中占主导。仅107例病例可进行基因分型。在HCV基因型中,基因型3(58.9%)是最常鉴定出的,其次是基因型1(34.6%)。血液透析(21.5%)、输血史(16.4%)和注射吸毒(11.9%)是HCV感染的主要危险因素,而肝硬化(7.3%)和脂肪性肝病(4%)是最常观察到的慢性HCV并发症。配偶/伴侣中的HCV感染(21.5%)、饮酒(7.3%)以及与乙型肝炎病毒(2.3%)和人类免疫缺陷病毒(1.7%)的合并感染是在我们研究人群中检测到的其他重要因素。

结论

HCV是一种导致严重慢性并发症的多因素疾病,因此构成公共卫生威胁。这清楚地强调了开展HCV社区宣传活动以及加强阿曼国家早期筛查高危人群指南以及有效管理HCV感染病例的重要性,以减轻该疾病对患者以及医疗系统的巨大负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/11410161/d0131a85a0d9/JEHP-13-208-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/11410161/d0131a85a0d9/JEHP-13-208-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/11410161/d0131a85a0d9/JEHP-13-208-g001.jpg

相似文献

1
Risk factors and outcome of hepatitis C infection among patients in a secondary care hospital: A 5-year retrospective study.二级护理医院患者丙型肝炎感染的危险因素及结局:一项5年回顾性研究。
J Educ Health Promot. 2024 Jul 11;13:208. doi: 10.4103/jehp.jehp_1326_23. eCollection 2024.
2
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
3
Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.附录:美国国立卫生研究院2002年丙型肝炎共识发展会议管理办法
Clin Liver Dis. 2003 Feb;7(1):261-87. doi: 10.1016/s1089-3261(02)00078-8.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Hepatitis B virus and hepatitis C virus co-infection in hemodialysis patients: A retrospective study from a tertiary care hospital of North India.印度北部一家三级护理医院对血液透析患者中乙型肝炎病毒和丙型肝炎病毒合并感染的回顾性研究。
J Nat Sci Biol Med. 2016 Jan-Jun;7(1):72-4. doi: 10.4103/0976-9668.175076.
6
Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.预测英国注射相关丙型肝炎病毒流行的严重后遗症。第1部分:重症丙型肝炎和注射者数据。
J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85.
7
Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.法国和意大利的1b型(II型)丙型肝炎病毒感染。协作研究组
Ann Intern Med. 1995 Feb 1;122(3):161-8. doi: 10.7326/0003-4819-122-3-199502010-00001.
8
Correlation between histologic staging, hepatitis C virus genotypes and clinical features in HCV chronic hepatitis: evidence of a new pattern.丙型肝炎病毒慢性肝炎的组织学分期、基因型与临床特征之间的相关性:一种新模式的证据
Int J Surg Pathol. 2003 Jul;11(3):197-204. doi: 10.1177/106689690301100306.
9
Treatment of chronic hepatitis C in Asia: when East meets West.亚洲慢性丙型肝炎的治疗:当东方与西方相遇时。
J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x.
10
Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.普通人群中丙型肝炎病毒相关肝病的临床病程及危险因素:狄俄尼索斯研究报告
Gut. 1999 Jun;44(6):874-80. doi: 10.1136/gut.44.6.874.

本文引用的文献

1
Challenges Facing Viral Hepatitis C Elimination in Lebanon.黎巴嫩在消除丙型病毒性肝炎方面面临的挑战
Pathogens. 2023 Mar 9;12(3):432. doi: 10.3390/pathogens12030432.
2
Gender differences in prevalence of hepatitis C virus infection in Egypt: a systematic review and meta-analysis.埃及丙型肝炎病毒感染患病率的性别差异:系统评价和荟萃分析。
Sci Rep. 2023 Feb 13;13(1):2499. doi: 10.1038/s41598-023-29262-z.
3
Gender-Specific Frequency Distribution of Hepatitis C Virus Genotypes in Punjab province, Pakistan: A Clinically Significant Descriptive Cross-Sectional Study.
巴基斯坦旁遮普省丙型肝炎病毒基因型的性别特异性频率分布:一项具有临床意义的描述性横断面研究。
Cureus. 2021 Aug 27;13(8):e17480. doi: 10.7759/cureus.17480. eCollection 2021 Aug.
4
Hepatitis C virus vaccine design: focus on the humoral immune response.丙型肝炎病毒疫苗设计:关注体液免疫应答。
J Biomed Sci. 2020 Jul 6;27(1):78. doi: 10.1186/s12929-020-00669-4.
5
Re-treatment of Hepatitis C Infection After Multiple Failures of Direct-Acting Antiviral Therapy.直接抗病毒治疗多次失败后丙型肝炎感染的再治疗
Open Forum Infect Dis. 2020 Mar 16;7(4):ofaa095. doi: 10.1093/ofid/ofaa095. eCollection 2020 Apr.
6
Hepatitis C Virus Infection in Children and Pregnant Women: An Updated Review of the Literature on Screening and Treatments.儿童和孕妇的丙型肝炎病毒感染:关于筛查和治疗的文献最新综述
AJP Rep. 2020 Jan;10(1):e121-e127. doi: 10.1055/s-0040-1709185. Epub 2020 Mar 31.
7
Overview of hepatitis C infection, molecular biology, and new treatment.丙型肝炎感染概述、分子生物学和新治疗方法。
J Infect Public Health. 2020 May;13(5):773-783. doi: 10.1016/j.jiph.2019.11.015. Epub 2019 Dec 20.
8
Mass screening for hepatitis B and C in Southern Upper Egypt.在上埃及南部进行乙型肝炎和丙型肝炎大规模筛查。
BMC Public Health. 2019 Oct 22;19(1):1326. doi: 10.1186/s12889-019-7640-1.
9
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study.全球、区域和国家级别的注射吸毒对丙型肝炎病毒传播的贡献:一项建模研究。
Lancet Gastroenterol Hepatol. 2019 Jun;4(6):435-444. doi: 10.1016/S2468-1253(19)30085-8. Epub 2019 Apr 10.
10
Neuropsychiatric symptoms in hepatitis C patients resemble those of patients with autoimmune liver disease but are different from those in hepatitis B patients.丙型肝炎患者的神经精神症状与自身免疫性肝病患者相似,但与乙型肝炎患者不同。
J Viral Hepat. 2019 Apr;26(4):422-431. doi: 10.1111/jvh.12979. Epub 2019 Jan 28.